You are here:Home-Chemical Inhibitors & Agonists-GPCR-CGRP Receptor-BMS-694153
BMS-694153

Chemical Structure : BMS-694153

CAS No.: 1050381-35-5

BMS-694153 (BMS 694153)

Catalog No.: PC-21156Not For Human Use, Lab Use Only.

BMS-694153 is a potent, selective calcitonin gene-related peptide (CGRP) receptor antagonist with Ki of 0.013 nM for hCGRP (inhibition of 125I-CGRP binding in SK-N-MC cell membranes).

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

BMS-694153 is a potent, selective calcitonin gene-related peptide (CGRP) receptor antagonist with Ki of 0.013 nM for hCGRP (inhibition of 125I-CGRP binding in SK-N-MC cell membranes).
BMS-694153 is a full, competitive antagonist, potently inhibits CGRP-stimulated cAMP production in SK-N-MC cells with EC50 of 0.0345 nM.
BMS-694153 show species-specific differences with relatively poor activity against nonprimate receptors, shows no inhibition of CGRP binding to the rat receptor at 1 uM.
BMS-694153 displays >10000-fold selectivity for CGRP over adrenomedullin receptors 1 and 2, calcitonin, and amylin receptors 1 and 3.
BMS-694153 shows no significant potential for off-target liabilities in a broad panel of receptor and ion channel binding and enzyme activity assays.
BMS-694153 potently reverses CGRP-induced dilation with EC50 of 0.06 nM in ex vivo human intracranial arteries.
BMS-694153 has good intranasal bioavailablity in rabbits and shows dose-dependent activity in validated in vivo and ex vivo migraine models.

Physicochemical Properties

M.Wt 644.80
Formula C35H45FN8O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide

References

1. Andrew P. Degnan, et al. Journal of Medicinal Chemistry  2008, 51, 16, 4858-4861.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: